These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10860877)

  • 1. Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.
    Kajumo F; Thompson DA; Guo Y; Dragic T
    Virology; 2000 Jun; 271(2):240-7. PubMed ID: 10860877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
    Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
    Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    Chabot DJ; Zhang PF; Quinnan GV; Broder CC
    J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells.
    Vicenzi E; Panina-Bodignon P; Vallanti G; Di Lucia P; Poli G
    J Leukoc Biol; 2002 Nov; 72(5):913-20. PubMed ID: 12429712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
    Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
    Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.
    Thompson DA; Cormier EG; Dragic T
    J Virol; 2002 Mar; 76(6):3059-64. PubMed ID: 11861874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
    Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR
    J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
    Pontow S; Ratner L
    J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
    Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
    J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
    Brelot A; Heveker N; Montes M; Alizon M
    J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry.
    Picard L; Wilkinson DA; McKnight A; Gray PW; Hoxie JA; Clapham PR; Weiss RA
    Virology; 1997 Apr; 231(1):105-11. PubMed ID: 9143308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X4-tropic human immunodeficiency virus IIIB utilizes CXCR4 as coreceptor, as distinct from R5X4-tropic viruses.
    Islam S; Hoque SA; Adnan N; Tanaka A; Jinno-Oue A; Hoshino H
    Microbiol Immunol; 2013 Jun; 57(6):437-44. PubMed ID: 23773022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
    Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
    Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes.
    Yi Y; Shaheen F; Collman RG
    J Virol; 2005 Feb; 79(3):1480-6. PubMed ID: 15650174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.